VYNE Therapeutics Inc. reports

Location: Bridgewater, NJ
Fiscal year end: 31 December

VYNE Therapeutics Inc. has filed 618 SEC EDGAR filings since 07 Jan 2013

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 51-75 of 618 matching filings.

Per page

25

Current page

3

SCHEDULE 13G/A File 005-90268

SCHEDULE 13G/A filing

Filing date: 15 May 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-38356

10-Q

Filing date: 08 May 2025
Reporting date: 31 Mar 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38356

8-K

Filing date: 08 May 2025
Reporting date: 08 May 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

4 filing

Filing date: 02 Apr 2025
Reporting date: 31 Mar 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 02 Apr 2025
Reporting date: 31 Mar 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 02 Apr 2025
Reporting date: 31 Mar 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 02 Apr 2025
Reporting date: 31 Mar 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

10-K File 001-38356

10-K

Filing date: 06 Mar 2025
Reporting date: 31 Dec 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38356

8-K

Filing date: 06 Mar 2025
Reporting date: 06 Mar 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

4 filing

Filing date: 23 Jan 2025
Reporting date: 21 Jan 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 23 Jan 2025
Reporting date: 21 Jan 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 23 Jan 2025
Reporting date: 21 Jan 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 23 Jan 2025
Reporting date: 21 Jan 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 16 Jan 2025
Reporting date: 15 Jan 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38356

FORM 8-K

Filing date: 13 Jan 2025
Reporting date: 13 Jan 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

4 filing

Filing date: 02 Jan 2025
Reporting date: 31 Dec 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 02 Jan 2025
Reporting date: 31 Dec 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 02 Jan 2025
Reporting date: 31 Dec 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 02 Jan 2025
Reporting date: 31 Dec 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38356

FORM 8-K

Filing date: 23 Dec 2024
Reporting date: 23 Dec 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

S-8 File 333-283940

FORM S-8

Filing date: 19 Dec 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 13 Dec 2024
Reporting date: 12 Dec 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 13 Dec 2024
Reporting date: 12 Dec 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 13 Dec 2024
Reporting date: 12 Dec 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 13 Dec 2024
Reporting date: 12 Dec 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .